Zhang, C., Duan, S., Guo, M., Yuan, Y., Huang, Z., Zhu, J., . . . Xing, C. (2020). Effects of CYP3A5 Polymorphisms on Efficacy and Safety of Tacrolimus Therapy in Patients with Idiopathic Membranous Nephropathy. Pharmgenomics Pers Med.
استشهاد بنمط شيكاغوZhang, Chengning, Suyan Duan, Miao Guo, Yanggang Yuan, Zhimin Huang, Jingfeng Zhu, Bin Sun, Bo Zhang, و Changying Xing. "Effects of CYP3A5 Polymorphisms On Efficacy and Safety of Tacrolimus Therapy in Patients With Idiopathic Membranous Nephropathy." Pharmgenomics Pers Med 2020.
MLA استشهادZhang, Chengning, et al. "Effects of CYP3A5 Polymorphisms On Efficacy and Safety of Tacrolimus Therapy in Patients With Idiopathic Membranous Nephropathy." Pharmgenomics Pers Med 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.